Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.

A 9.5-year-old girl after Fontan procedure for hypoplastic left heart syndrome had recurrent protein-losing enteropathy (PLE) develop 2 months after partial catheter closure of the Fontan fenestration. Despite satisfactory hemodynamic measurements under general anesthesia, we postulated that she suffered from increased pulmonary vascular reactivity and commenced her on Sildenafil treatment. After 6 weeks of oral Sildenafil treatment, her serum albumin and the fecal alpha-1-antitrypsin levels normalized, and her exercise tolerance had increased. There was also an improvement of the mesenteric arterial flow patterns on Doppler studies. Sildenafil should be considered in the treatment of PLE after the Fontan procedure.

[1]  R. Cha,et al.  Protein-losing enteropathy after the Fontan operation. , 1996, The Journal of thoracic and cardiovascular surgery.

[2]  D. Hagler,et al.  Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. , 1998, The Journal of thoracic and cardiovascular surgery.

[3]  S. Archer,et al.  Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension Comparison With Inhaled Nitric Oxide , 2002 .

[4]  Hudson Freeze,et al.  Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms. , 2006, The Annals of thoracic surgery.

[5]  G. Jackson,et al.  Effects of sildenafil citrate on human hemodynamics. , 1999, The American journal of cardiology.

[6]  A. Rosenthal,et al.  Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. , 1997, The Journal of pediatrics.

[7]  J. Rychik,et al.  Atrial pacing: an alternative treatment for protein-losing enteropathy after the Fontan operation. , 2001, The Journal of thoracic and cardiovascular surgery.

[8]  J. Rychik,et al.  Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. , 1991, The American journal of cardiology.

[9]  Jack Rychik,et al.  Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. , 2002, The American journal of cardiology.